Angiotensin IV comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-05-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
| Property | Value | Notes |
|---|---|---|
| Primary proposed target | HGF/c-Met signaling | Direct binding not confirmed |
| Research models | Rodent and cell studies | Preclinical only |
| Human clinical data | None published | Safety and efficacy unknown |
| Regulatory status | Unapproved research chemical | Status varies by country |
| Typical research purity | 95% or higher by HPLC | Depends on supplier and batch |
The compound has been examined in animal models for effects on learning, memory, and synaptic connectivity. Some reports describe increased dendritic spine density and improved performance on certain behavioral tasks after administration in rodents. These findings are often cited in discussions of nootropic research peptides, but replication across independent laboratories remains limited. The absence of published phase 1 or phase 2 clinical trial data makes it difficult to assess safety, effective routes, or long-term outcomes in humans. Consequently, claims about cognitive benefits in people remain speculative.
Dihexa is not approved as a medicine in major regulatory jurisdictions. It is commonly sold as a research chemical for laboratory use, though such products may not be standardized or independently verified. Scientific literature on dihexa includes in vitro assays, rodent studies, and reviews that discuss its proposed mechanism. The distinction between peer-reviewed findings and commercial promotion is important when evaluating available information. Open questions include its precise binding interactions, pharmacokinetics, and whether animal results translate to human biology.
Dihexa is a synthetic peptide derived from angiotensin IV, a naturally occurring fragment of the renin-angiotensin system. Researchers modified the angiotensin IV structure to improve metabolic stability and central nervous system activity. It is frequently described as a hepatocyte growth factor mimetic because it can activate the c-Met receptor pathway in experimental systems. Its development reflects interest in small peptides that influence synaptic plasticity and cognitive processes. Most information comes from preclinical studies rather than controlled human trials.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
International Order of Twelve Knights and Daughters of Tabor Knights of Peter Claver - Founded in 1909 by members of Most Pure Heart of Mary Catholic Church in Mobile, Alabama, as a Black Catholic fraternal order, as Blacks were barred from the Knights of Columbus due to their race. Among the founders were The Rev. John H. Dorsey (the second Black Catholic priest ordained in the US), several White priests, and three Black parishioners. Knights of Pythias of North America, South America, Europe, Asia, Africa and Australia and the women's auxiliary organization, Order of Calanthe Mosaic Templars of America Order of Galilean Fishermen - Founded in 1856 in Baltimore, Maryland, by Hemsley Nichols. One of the oldest orders of its kind, by 1897 it was also one of the wealthiest with $125,000 in lodges, land, personal property and bonds. By that time it had 56,000 members in lodges "from New England to the Gulf." Men and women were admitted. The Order paid sick and death benefits which in 1897 were $5 per day for sickness and $300 to $400 for death. Claimed to be of Masonic origin, its emblem used a fish, cross rose and the letters INRI, similar to the 18th degree in Scottish Rite Masonry. Local lodges were called "Tabernacles." active into the 1980s. Prince Hall Freemasonry and the auxiliary groups, Prince Hall Order of the Eastern Star and Heroines of Jericho. Also, splinter groups such as National Grand Lodge Free & Accepted Ancient York Masons Prince Hall Origin National Compact USA Supreme Camp of American Woodmen United African Brotherhood - Organized in Clinton, Texas.
Adolescent medicine Adult congenital heart disease Advanced heart failure and transplant cardiology Cardiovascular disease, dealing with disorders of the heart and blood vessels* Clinical cardiac electrophysiology Critical care medicine, is dealing with life-threatening conditions requiring intensive monitoring and treatment. Endocrinology, diabetes & metabolism, dealing with disorders of the endocrine system and its specific secretions called hormones Gastroenterology, concerned with the field of digestive diseases Geriatric medicine Hematology, concerned with blood, the blood-forming organs and its disorders. Hospice & palliative medicine Infectious disease, concerned with disease caused by a biological agent such as by a virus, bacterium or parasite Interventional cardiology Medical oncology, dealing with the chemotherapeutic (chemical) and/or immunotherapeutic (immunological) treatment of cancer Nephrology, dealing with the study of the function and diseases of the kidney Neurocritical care Pulmonary disease, dealing with diseases of the lungs and the respiratory tract Rheumatology, devoted to the diagnosis and therapy of rheumatic diseases Sleep medicine Sports medicine Transplant hepatology
Thirty years later, this work inspired, independently, two research groups to adopt the H-phosphonate chemistry to the solid-phase synthesis using nucleoside H-phosphonate monoesters 7 as building blocks and pivaloyl chloride, 2,4,6-triisopropylbenzenesulfonyl chloride (TPS-Cl), and other compounds as activators. The practical implementation of H-phosphonate method resulted in a very short and simple synthetic cycle consisting of only two steps, detritylation and coupling (Scheme 2). Oxidation of internucleosidic H-phosphonate diester linkages in 8 to phosphodiester linkages in 9 with a solution of iodine in aqueous pyridine is carried out at the end of the chain assembly rather than as a step in the synthetic cycle. If desired, the oxidation may be carried out under anhydrous conditions. Alternatively, 8 can be converted to phosphorothioate 10 or phosphoroselenoate 11 (X = Se), or oxidized by CCl4 in the presence of primary or secondary amines to phosphoramidate analogs 12. The method is very convenient in that various types of phosphate modifications (phosphate/phosphorothioate/phosphoramidate) may be introduced to the same oligonucleotide for modulation of its properties. Most often, H-phosphonate building blocks are protected at the 5'-hydroxy group and at the amino group of nucleic bases A, C, and G in the same manner as phosphoramidite building blocks (see below). However, protection at the amino group is not mandatory.
Sources: en.wikipedia.org
==== Employee opposition to AI militarisation ==== In May 2026, workers at Google DeepMind's London headquarters voted to unionise, requesting joint representation by the Communication Workers Union (CWU) and Unite the Union. The unionisation drive was heavily motivated by ethical concerns regarding Google's military-industrial AI contracts, specifically the provision of AI technology to the US Department of Defense and the Israeli military.
=== Dentition === Komodo dragons have ziphodont teeth, which are defined as teeth that are laterally flattened, recurved, and with serrated tooth crowns where the serrations have a dentine core and a very thin enamel outer layer. This is the same type of dentition observed in many extinct theropod dinosaurs. The teeth of the insectivorous juveniles in contrast are barely recurved, with fewer and less well-developed serrations that lack dentine cores.
=== RMI Staffing === Remote Medical International medical providers are available for onsite deployments operating in remote areas worldwide. Medical providers include experienced EMTs, paramedics, physician assistants, nurses, and doctors who respond to routine and emergent medical incidents. RMI medics are most commonly deployed on offshore seismic research vessels and land-based mineral exploration and production sites.
==== Translation ==== Two different sets of proteins are translated from viral mRNAs. The first set is represented by six structural proteins that include nucleocapsid protein (NP), phosphoprotein (P), matrix protein (M), fusion protein (F), neuraminidase (NA) and large protein (L). All these proteins have variable functions and are incorporated into the viral capsid (see the section "Virion structure" above). The second set is represented by seven non structural or accessory proteins. These proteins are translated from the polycistronic mRNA of P gene. This mRNA encodes eight translation products, and P-protein is only one of them. Alternative variants of translation are represented by V, W, C, C′, Y, Y′ and X proteins. The proteins C′, C, Y1, Y2 are products of mRNA alternative reading frame, they collectively referred as C-proteins or C-nested proteins and they share common C-terminal end. The X protein also shares the same C-terminal end and its translation also independently initiated by ribosomes. The proteins V and W are products of cotranscriptional mRNA editing. All these non-structural proteins have multiple functions, including the organization of viral RNA synthesis and helping the virus to infect host cells by escaping host innate immunity (see "Virus-induced immunosuppression" section above).
Sources: en.wikipedia.org
=== A. tumefaciens === Production of siderophores also exhibited in some plant-infecting bacteria, such as Agrobacterium tumefaciens. The enzyme is controlled by gene cluster agb and the production of 2,3-diDHB dehydrogenase is controlled by the gene agbA. The enzyme AgbA is homologous to the EntA enzyme in E. coli, the same enzyme that produces 2,3-diDHB dehydrogenase.
=== Mechanisms of resistance === A major mechanism of resistance against piperacillin-tazobactam is Gram-negative bacteria producing β-lactamases. Other currently known mechanisms include mutations in the active site of penicillin-binding proteins, changes in membrane efflux, or bacteria permeability. Some enzymes, such as extended-spectrum β-lactamase (ESBL) have evolved from narrow-spectrum β-lactamases due to genetic mutations, increasing their capabilities to hydrolyze much broader spectrum penicillin. Due to prior conflicting reports on the drug's affinity with ESBL-producing bacteria, piperacillin-tazobactam treatment for such is not recommended. Antibiotic resistance occurs sporadically, conferred by the continuous use of piperacillin-tazobactam in situations where it may prove to be ineffective, leading to cases where plasmid-mediated β-lactamases are being produced in bacteria that do not naturally produce it. Some Gram-positive bacteria penicillin-binding proteins such as Enterococcus faecium (PBP-5) or Staphylococcus aureus (PBP-2a) are intrinsically antibiotic resistant, consisting of relatively low affinity with piperacillin and therefore high resistance to piperacillin-tazobactam. Furthermore, mutations in penicillin-binding proteins cause fluctuations in piperacillin affinity, whereas Streptococcus pneumoniae (PBP-2b) autolytic response is significantly reduced due to decreased affinity with piperacillin.
Mothers who take certain recreational drugs should not breastfeed, however, most medications are compatible with breastfeeding. Available evidence indicates that it is unlikely that COVID-19 can be transmitted through breast milk. Smoking tobacco and consuming limited amounts of alcohol or coffee are not reasons to avoid breastfeeding.
=== DNA test === The muscle-specific isoform of the dystrophin gene is composed of 79 exons, and DNA testing (blood test) and analysis can usually identify the specific type of mutation of the exon or exons that are affected. DNA testing confirms the diagnosis in most cases.
=== Laurent's half-shade polarimeter === When plane-polarised light passes through some crystals, the velocity of left-polarized light is different from that of the right-polarized light, thus the crystals are said to have two refractive indices, i.e. double refracting. Construction: The polarimeter consists of a monochromatic source S which is placed at focal point of a convex lens L. Just after the convex lens there is a Nicol Prism P which acts as a polariser. H is a half shade device which divides the field of polarized light emerging out of the Nicol P into two halves, generally of unequal brightness. T is a glass tube in which an optically active solution is filled. The light, after passing through T, is allowed to fall on the analyzing Nicol A which can be rotated about the axis of the tube. The rotation of the analyzer can be measured with the help of a scale C. Working principle: To understand the need of a half-shade device, let us suppose that it is not present. The position of the analyzer is adjusted so that the field of view is dark when the tube is empty. The position of the analyzer is noted on the circular scale. Now the tube is filled with the optically active solution and it is set in its proper position. The optically active solution rotates the plane of polarization of the light emerging out of the polarizer P by some angle, so the light is transmitted by analyzer A and the field of view of the telescope becomes bright. Now the analyzer is rotated by a finite angle so that the field of view of the telescope again becomes dark.
Sources: en.wikipedia.org
Dihexa has been proposed to act through HGF and c-Met signaling. This pathway is linked to synapse formation and cellular growth. Direct binding and the precise molecular step remain uncertain.
No published human clinical trials are available for dihexa. Its safety and effectiveness in people are therefore unknown. Most available evidence comes from animal and cell studies.
Preclinical studies often measure dendritic spine density and synaptic protein levels. Behavioral tests include maze learning and avoidance tasks. These endpoints are indirect and do not establish clinical benefit.
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.